CDTX
Price
$48.78
Change
+$0.91 (+1.90%)
Updated
Jul 3 closing price
Capitalization
1B
PTIX
Price
$3.46
Change
-$0.02 (-0.57%)
Updated
Jul 3 closing price
Capitalization
3.02M
Interact to see
Advertisement

CDTX vs PTIX

Header iconCDTX vs PTIX Comparison
Open Charts CDTX vs PTIXBanner chart's image
Cidara Therapeutics
Price$48.78
Change+$0.91 (+1.90%)
Volume$412.73K
Capitalization1B
Protagenic Therapeutics
Price$3.46
Change-$0.02 (-0.57%)
Volume$140.79K
Capitalization3.02M
CDTX vs PTIX Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. PTIX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and PTIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (CDTX: $48.78 vs. PTIX: $3.46)
Brand notoriety: CDTX and PTIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 64% vs. PTIX: 6%
Market capitalization -- CDTX: $1B vs. PTIX: $3.02M
CDTX [@Biotechnology] is valued at $1B. PTIX’s [@Biotechnology] market capitalization is $3.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whilePTIX’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • PTIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDTX and PTIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while PTIX’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • PTIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CDTX and PTIX are a good buy in the short-term.

Price Growth

CDTX (@Biotechnology) experienced а +1.56% price change this week, while PTIX (@Biotechnology) price change was -10.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CDTX is expected to report earnings on May 08, 2025.

PTIX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1B) has a higher market cap than PTIX($3.02M). CDTX YTD gains are higher at: 81.473 vs. PTIX (-49.563). PTIX has higher annual earnings (EBITDA): -5.18M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. PTIX (873K). PTIX has less debt than CDTX: PTIX (420K) vs CDTX (2.67M). CDTX has higher revenues than PTIX: CDTX (302K) vs PTIX (0).
CDTXPTIXCDTX / PTIX
Capitalization1B3.02M33,124%
EBITDA-192.6M-5.18M3,715%
Gain YTD81.473-49.563-164%
P/E RatioN/AN/A-
Revenue302K0-
Total Cash168M873K19,244%
Total Debt2.67M420K636%
FUNDAMENTALS RATINGS
CDTX vs PTIX: Fundamental Ratings
CDTX
PTIX
OUTLOOK RATING
1..100
2713
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3492
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTIX's Valuation (25) in the null industry is somewhat better than the same rating for CDTX (86) in the Biotechnology industry. This means that PTIX’s stock grew somewhat faster than CDTX’s over the last 12 months.

PTIX's Profit vs Risk Rating (100) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

PTIX's SMR Rating (100) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for PTIX (92) in the null industry. This means that CDTX’s stock grew somewhat faster than PTIX’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PTIX (100) in the null industry. This means that CDTX’s stock grew similarly to PTIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXPTIX
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSQAX17.71N/A
N/A
Invesco MSCI World SRI Index A
FHEIX17.04N/A
N/A
Fidelity Advisor Real Estate I
FRUAX24.20N/A
N/A
Franklin Utilities Adv
BMSBX14.64N/A
N/A
MFS Blended Research Mid Cap Eq B
ANVMX10.50N/A
N/A
American Century Non-US Intrs ValR6

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+1.90%
BPTSY - CDTX
92%
Closely correlated
N/A
UNCY - CDTX
52%
Loosely correlated
-0.86%
INDP - CDTX
41%
Loosely correlated
+2.78%
IVVD - CDTX
36%
Loosely correlated
+1.67%
TERN - CDTX
36%
Loosely correlated
+1.41%
More

PTIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTIX has been loosely correlated with ARMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTIX jumps, then ARMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
-0.57%
ARMP - PTIX
45%
Loosely correlated
+11.86%
TNGX - PTIX
27%
Poorly correlated
+0.88%
SQZB - PTIX
26%
Poorly correlated
N/A
CDTX - PTIX
25%
Poorly correlated
+1.90%
OCGN - PTIX
25%
Poorly correlated
+3.30%
More